spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

YHEC announces the promotions of Michelle Jenks and Rachael McCool to the role Project Director

YHEC

Michelle Jenks and Rachael McCool announced as YHEC Project Directors

YHEC is pleased to announce the promotions of Michelle Jenks from the Economic Modelling team and Rachael McCool from the Systematic Reviewing team to the role Project Director.

Michelle has a Masterís degree (MSc) in health economics from the University of York and has conducted economic evaluations and systematic reviews for both public and private sector clients. Michelle is the lead modeller in YHECís role as an External Assessment Centre for NICE and has also led on a range of economic evaluations conducted for clients within industry, such as cost-utility models and budget impact models. She often leads the development of early economic analyses to inform clinical trial design and pricing strategy.

Rachael has a BSc (Hons) in psychology from the University of York and has developed extensive experience in systematic reviewing and mixed treatment comparisons during her time at YHEC. Rachael has led systematic reviews requiring both quantitative and qualitative analyses and has worked on several reviews to support reimbursement submissions to NICE and other HTA bodies. She has also contributed to critiques of evidence submitted to NICEís medical technologies evaluation program. In her previous role, Rachael worked on developing and validating patient reported outcome measures using qualitative methods as well as critiquing existing measures against regulatory agency standards. She has worked with clients to assist them in their choice of PRO endpoint and outcome assessment in trials.
phone +44 (0)1904 323620
email andria.hanbury@york.ac.uk
web www.yhec.co.uk/
email Address: YHEC, Enterprise House, Innovation Way, University of York, York, YO10 5NQ, United Kingdom
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Prometic Bioseparations are very pleased to introduce their new purpose built ecommerce platform (Webshop)!

Their goal was to build a platform that is easy to navigate, informative and one that makes their products and services easily accessible to researchers and laboratories worldwide. They also wanted to make ordering as quick and easy as possible to meet the needs of the rapidly progressive industry. They have reflected these requirements with an ecommerce store in order to supply high quality products to customers from academia to big pharma.
More info >>


White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem ó which CMO should you pick when each is touting similar technical capabilities?
More info >>

Industry Events

5th Biennial Biosimilars & Biobetters Congress 2018

16-17 April 2018, Novotel London West Hotel, Hammersmith, London

Oxford Global are proud to present our highly anticipated 5thBiennial Biosimilars & Biobetters Congress, 16th Ė 17thApril 2018, London, UK. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will enjoy over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement